Ziegler Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Ziegler Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-31,940	Closed	-$880K	–	455
2021 Q2	$880K	Buy	+31,940	New	+$628K	0.03%	347

Ziegler Capital Management's TBIO Position: Q3 2021 in Review

Ziegler Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 31,940 shares — an estimated $880K sold.

Ziegler Capital Management first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $880K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Ziegler Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Ziegler Capital Management sold 31,940 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $880K.
Ziegler Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Ziegler Capital Management's Translate Bio, Inc. Common Stock position peaked at $880K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Ziegler Capital Management's 13F filing for Q3 2021, filed 27 Oct 2021.